Artivion Inc

Healthcare · Medical Devices

22.60$ -1.7% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Artivion Inc (AORT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 885 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet AORT
Line item	1996	1997	1998	1999	2000	2001	2002	2003	2004	2005	2006	2007	2008	2009	2010	2011	2012	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025
Total Assets	35	54	98	94	112	129	106	75	73	77	80	93	126	134	137	148	157	175	176	181	316	592	571	606	789	793	763	792	789	885
Current Assets	18	25	72	68	79	84	62	36	38	45	49	65	80	96	101	84	78	106	106	110	147	179	179	187	235	248	247	281	290	304
Cash	1.4	0.1	13	6.1	17	7.2	10	5.7	4.7	6.6	4.1	14	17	30	35	22	18	43	33	43	57	41	41	34	61	55	39	59	53	65
Cash & Short-Term Investments	1.4	0.1	13	31	39	34	25	11	8.7	12	8.1	17	17	30	35	22	18	43	33	43	57	41	41	34	61	55	39	59	53	65
Receivables	8.2	10	11	12	15	17	19	8.2	12	12	14	14	14	15	14	18	17	18	23	27	30	51	51	56	49	58	70	74	86	104
Inventory	0.3	1.8	3.4	4.6	4.0	6.3	4.6	4.5	4.8	4.6	5.2	5.6	7.1	6.4	6.4	7.3	11	9.8	13	15	26	47	45	53	73	77	74	82	80	92
Property, Plant & Equipment	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	34	31	54	52	83	39	–	–	–
Goodwill	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	4.2	11	11	11	11	78	188	189	187	260	250	244	247	241	254
Intangible Assets	4.7	12	3.9	4.0	6.5	4.3	5.3	5.6	5.4	5.3	7.6	7.1	6.7	7.0	8.9	20	24	22	21	20	67	179	160	158	227	201	183	172	156	156
Total Liabilities	10	24	18	14	23	28	27	27	24	26	28	30	27	23	23	26	29	30	27	26	107	313	296	320	461	492	478	511	513	437
Current Liabilities	7.2	6.3	9.4	7.6	11	18	24	21	18	21	23	25	21	19	19	21	21	21	21	20	30	43	35	45	60	45	50	58	67	102
Short-Term Debt	–	1.5	0.7	0.5	1.1	6.6	7.8	1.7	1.3	5.1	4.5	4.5	14	11	11	13	14	14	–	–	4.6	1.9	2.6	7.2	7.6	5.3	5.4	5.4	5.3	5.4
Accounts Payable	3.7	1.6	1.7	1.0	2.9	0.6	3.9	2.2	2.6	2.2	2.5	3.0	3.3	3.0	4.2	4.4	3.8	4.1	4.5	4.6	5.7	9.8	7.5	9.8	9.6	10	12	13	18	16
Long-Term Debt	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	216	215	290	307	306	306	314	215
Shareholders' Equity	25	30	80	80	89	101	80	48	50	51	52	63	99	110	114	122	128	145	149	155	209	279	275	286	329	301	284	282	276	448
Retained Earnings	7.9	13	19	24	31	41	13	-20	-38	-59	-59	-53	-20	-12	-8.4	-1.0	5.5	19	23	23	34	38	35	37	20	2.0	-17	-48	-61	-51
Shares Outstanding	15	15	18	19	19	20	19	20	23	24	25	27	28	28	28	28	27	28	28	29	33	34	36	38	38	39	40	41	42	47

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings